Global Canna Labs successfully exports Medical Cannabis from Jamaica to Canada
05 December 2019 - 12:30AM
Elixxer Ltd. (TSX-V: ELXR and OTC-QB: ELXIF)
(“
ELIXXER”) is pleased to announce that Global
Canna Labs has successfully exported 10 kilograms of medical
cannabis from Jamaica into Canada.
This shipment of medical cannabis, the largest
of its kind known to date, is a significant step forward in the
development of Jamaica’s medical, therapeutic and scientific
cannabis industry. The Caribbean Licensing Authority, CLA,
has been working diligently on creating a viable export
platform. Jamaica’s Minister of Industry, Commerce,
Agriculture and Fisheries, the Honorable Audley Shaw applauded the
news as he recently presented at the CanEx Investment Summit in
Toronto on November 28th.
For further information please refer to:
Jamaican Observer, December 4th, 2019:
http://www.jamaicaobserver.com/news/jamaica-sends-legal-shipment-of-cannabis-to-canada_181208?profile=1373
About Elixxer Ltd.
(www.Elixxer.com)
Elixxer Ltd. is a Canadian incorporated public
company listed on the TSX Venture Exchange (TSX-V: ELXR) and the US
OTC-QB exchange (OTCQB: ELXIF). It currently has investments in
legal cannabis related businesses in Australia, Jamaica,
Switzerland, Italy, and Canada.
For further information please
contact:
President, John McMullen, +1-416-803-0698,
john@elixxer.com Caution Regarding Press
Releases
Neither the TSX Venture Exchange nor its
Regulation Service Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Notice Regarding Forward Looking
Statements
This press release may contain forward-looking
statements with respect to Elixxer and its operations, strategy,
investments, financial performance and condition. These statements
can generally be identified by use of forward-looking words such as
“may”, “will”, “expect”, “estimate”, “anticipate”, “intends”,
“believe” or “continue” or the negative thereof or similar
variations. The actual results and performance of Elixxer could
differ materially from those expressed or implied by such
statements. Such statements are qualified in their entirety by the
inherent risks and uncertainties surrounding future expectations.
Some important factors that could cause actual results to differ
materially from expectations include, among other things, general
economic and market factors, competition, government regulation and
the factors described under “Risk Factors and Risk Management” in
Elixxer’s most recent Management’s Discussion and Analysis filed on
SEDAR (www.sedar.com). The cautionary statements qualify all
forward-looking statements attributable to Elixxer and persons
acting on its behalf. Unless otherwise stated, all forward-looking
statements speak only as of the date of this press release, and
Elixxer has no obligation to update such statements, except to the
extent required by applicable securities laws.
Elixxer (TSXV:ELXR)
Historical Stock Chart
From Sep 2024 to Oct 2024
Elixxer (TSXV:ELXR)
Historical Stock Chart
From Oct 2023 to Oct 2024